SGLT2 Inhibitors in Diabetic Kidney Disease: Renal Protection and Mechanisms
vumedi.com
SGLT2 Inhibitors in Diabetic Kidney Disease: Renal Protection and Mechanisms
You’re watching part 6 of Professor DeFronzo’s lecture on SGLT2 Inhibitors: Cardio-Renal-Metabolic Drugs for the Ages. To view the complete lecture: https://www.vumedi.com/video/sglt2-inhibitors-cardio-renal-metabolic-drugs-for-the-ages/Part 1: https://www.vumedi.com/video/cardiorenal-outcomes-with-sglt2-inhibitors-landmark-data-and ...
180 views4 months ago
SGLT2 Inhibitors Benefits
What are SGLT2 inhibitors and what are their benefits?
2:47
What are SGLT2 inhibitors and what are their benefits?
YouTubeDr Kevin Fernando
2K viewsApr 15, 2025
SGLT2 Inhibitor Medications: A Patient’s Guide to Uses, Costs, and Benefits (key points)
5:34
SGLT2 Inhibitor Medications: A Patient’s Guide to Uses, Costs, and Benefits (key points)
YouTubehealth
7 views7 months ago
SGLT2 Inhibitor Medications: A Patient’s Guide to Uses, Costs, and Benefits (article)
9:31
SGLT2 Inhibitor Medications: A Patient’s Guide to Uses, Costs, and Benefits (article)
YouTubehealth
12 views6 months ago
Top videos
SGLT-2 inhibitors reduce the risk of cardiovascular death or hospitalisation for heart failure in adults with chronic kidney disease
SGLT-2 inhibitors reduce the risk of cardiovascular death or hospitalisation for heart failure in adults with chronic kidney disease
ox.ac.uk
Nov 8, 2022
The role of SGLT2 inhibitors in Chronic Kidney Disease is no longer secondary. It is structural. Evidence now demonstrates significant renal protection and cardiovascular benefit, even beyond glycaemic control. For many patients with CKD, SGLT2 inhibitors are becoming a core component of disease modification, not an add-on. That shift has operational consequences. For practices and PCNs, it creates the need to: • Proactively identify eligible CKD cohorts • Review treatment pathways in line with
0:10
The role of SGLT2 inhibitors in Chronic Kidney Disease is no longer secondary. It is structural. Evidence now demonstrates significant renal protection and cardiovascular benefit, even beyond glycaemic control. For many patients with CKD, SGLT2 inhibitors are becoming a core component of disease modification, not an add-on. That shift has operational consequences. For practices and PCNs, it creates the need to: • Proactively identify eligible CKD cohorts • Review treatment pathways in line with
TikTokcoreprescribingsolutions
234 views2 months ago
Chart: When and When Not to Use An SGLT-2 Inhibitor
Chart: When and When Not to Use An SGLT-2 Inhibitor
diabetesincontrol.com
Aug 31, 2018
SGLT2 Inhibitors Side Effects
Common side effects of SGLT2 inhibitors and how to manage them
4:19
Common side effects of SGLT2 inhibitors and how to manage them
YouTubeDr Kevin Fernando
1.4K viewsApr 15, 2025
Let's discuss the side effects of SGLT2 Inhibitors such as Jardiance #diabetes #health #medicine #pharmacy #publichealth
0:51
Let's discuss the side effects of SGLT2 Inhibitors such as Jardiance #diabetes #health #medicine #pharmacy #publichealth
TikTokhealthnidus
973 views2 months ago
Type 2 Diabetes: The Effects of Different Antidiabetic Drug Classes on Mortality
2:03
Type 2 Diabetes: The Effects of Different Antidiabetic Drug Classes on Mortality
YouTubeJAMA Network
29.1K viewsJul 12, 2018
SGLT-2 inhibitors reduce the risk of cardiovascular death or hospitalisation for heart failure in adults with chronic kidney disease
SGLT-2 inhibitors reduce the risk of cardiovascular death or hospitalis…
Nov 8, 2022
ox.ac.uk
The role of SGLT2 inhibitors in Chronic Kidney Disease is no longer secondary. It is structural. Evidence now demonstrates significant renal protection and cardiovascular benefit, even beyond glycaemic control. For many patients with CKD, SGLT2 inhibitors are becoming a core component of disease modification, not an add-on. That shift has operational consequences. For practices and PCNs, it creates the need to: • Proactively identify eligible CKD cohorts • Review treatment pathways in line with
0:10
The role of SGLT2 inhibitors in Chronic Kidney Disease is no long…
234 views2 months ago
TikTokcoreprescribingsolutions
Chart: When and When Not to Use An SGLT-2 Inhibitor
Chart: When and When Not to Use An SGLT-2 Inhibitor
Aug 31, 2018
diabetesincontrol.com
Glucose Transport | Metabolism
10:09
Glucose Transport | Metabolism
106K viewsAug 20, 2019
YouTubeDr Matt & Dr Mike
Sodium Glucose Cotransporter Inhibitors
3:10
Sodium Glucose Cotransporter Inhibitors
23.8K viewsOct 27, 2020
YouTubeUSMLE pass
How do ACE inhibitors work?
2:12
How do ACE inhibitors work?
523.5K viewsOct 2, 2018
YouTubeBritish Heart Foundation
Short Heart Failure Pharmacology Video
2:24
Short Heart Failure Pharmacology Video
1.9M viewsAug 22, 2019
YouTubeSimpleNursing
7:08
Pharmacology - Diuretics (Part 2) - Carbonic Anhydrase Inhibitors
16.7K viewsMay 11, 2019
YouTubeMedinaz
6:52
How do ACE inhibitors work?
56.1K viewsSep 5, 2016
YouTubeZero To Finals
2:46
SGLT-2 Inhibitors (Mnemonic for the USMLE)
6.6K viewsOct 9, 2020
YouTubeAJmonics
5:41
SGLT-2 inhibitors and DKA
8K viewsOct 1, 2020
YouTubeMedication Quality and Safety Rx
6:57
How does Dapagliflozin work? Understanding SGLT2 inhibitors.
218.8K viewsJan 31, 2019
YouTubeZero To Finals
1:10
SGLT-2 Inhibitors - Mechanism of Action
26.9K viewsDec 10, 2017
YouTubeDr Rakesh SONAWANE
1:44
SGLT2 Inhibitors Mechanism of Action
57.1K viewsApr 26, 2021
YouTubeNonstop Neuron
53:09
SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
5.8K viewsOct 11, 2019
YouTubeIcahn School of Medicine
46:01
CKD E-Learning - SGLT-2 inhibitors and CKD - 05.19.21
4K viewsMay 20, 2021
YouTubeBC Renal
35:24
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidne…
36K viewsJan 2, 2019
YouTubeAt the Limits - Leading Medical Education
7:34
Glucose Transporters (GLUTs and SGLTs) - Biochemistry Lesson
269.6K viewsFeb 11, 2017
YouTubeJJ Medicine
2:34
SGLT2 Inhibitors (Dapagliflozin, empagliflozin) | Type 2 Diabetes re…
3.4K viewsJun 20, 2020
YouTubeDrugsPlus
13:49
Using SGLT2-inhibitors to treat cardiac patients with diabetes
36.3K viewsNov 14, 2018
YouTubeTed Rogers Centre for Heart Research
4:22
Farxiga FDA Approved Kidney Disease Treatment. Should You U…
36.8K viewsMay 5, 2021
YouTubeHealthyKidney Inc
16:10
How SGLT-2 Inhibitors Work: with Pros and Cons - Jardiance, Farxig…
21.7K viewsJan 28, 2021
YouTubeType 2 Diabetes - Dr. Vladmir Carvalho, MD, PhD
3:35
SGLT-2 Inhibitors, Explained: How They Work, Their Benefits and Risks
3.1K viewsNov 5, 2020
YouTubeCardioVisual
3:49
SGLT2 inhibitors (dapagliflozin, canagliflozin, empagliflozin) for di…
4.9K viewsApr 13, 2019
YouTubeAstroByte
2:03
Type 2 Diabetes: The Effects of Different Antidiabetic Drug Classe…
29.1K viewsJul 12, 2018
YouTubeJAMA Network
7:18
Do SGLT-2 Inhibitors Reduce Risk of Heart Failure? Doctors Discuss …
3.9K viewsFeb 22, 2021
YouTubeCardioVisual
0:49
SGLT2
21.2K viewsMar 30, 2015
YouTubeShaw Science Partners
5:13
SGLT2 Inhibitor trials - SUMMARY
1.3K viewsFeb 20, 2023
YouTubeDr Manoj Prabhakaran MD DM
8:15
SGLT2 Inhibitors and Heart Failure
50.1K viewsAug 1, 2022
YouTubeHarvard Medical School Continuing Education
See more videos
Static thumbnail place holder